申请人:Akzo N.V.
公开号:US04499105A1
公开(公告)日:1985-02-12
The present invention is dealing with compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, in which n and m represent the number 1 or 2, X and Y hydrogen, alkyl (1-4 C), alkoxy (1-4 C), hydroxy, halogen, hydroxymethyl, trifluoromethyl, acyl (1-4 C), acyloxy (1-4 C) or the group NR.sub.x R.sub.y, in which R.sub.x and R.sub.y represent hydrogen, alkyl (1-4 C) or a sulphonyl group and R represents the group ##STR2## in which R.sub.1 and R.sub.2 represent hydrogen, alkyl (1-4 C), hydroxy, alkoxy (1-4 C), phenylalkoxy (7-10 C), acyloxy, amino or mono or dialkyl (1-4 C) amino, having potent platelet aggregation inhibiting properties.
本发明涉及以下结构的化合物:##STR1##及其在药学上可接受的盐,其中n和m代表数字1或2,X和Y代表氢、烷基(1-4 C)、烷氧基(1-4 C)、羟基、卤素、羟甲基、三氟甲基、酰基(1-4 C)、酰氧基(1-4 C)或基团NR.sub.x R.sub.y,其中R.sub.x和R.sub.y代表氢、烷基(1-4 C)或磺酰基,R代表##STR2##其中R.sub.1和R.sub.2代表氢、烷基(1-4 C)、羟基、烷氧基(1-4 C)、苯基烷氧基(7-10 C)、酰氧基、氨基或单或二烷基(1-4 C)氨基,具有强效的抑制血小板聚集作用。